CryoPac is FDA approved for peripheral nerve applications and was released to the U.S. Market in March of 2005. It was developed as a niche product to meet portability and limited space requirements. The CryoPac's affordability, compact size and ease of use make it an ideal choice for podiatry practices. CryoPac features the essential functions and capabilities needed to perform cryoanalgesia where automated systems and neuro-stimulation are not required.